This message contains images. If you don't see images, click here to view.
Advertise in this news brief.

Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit February 25, 2015



American Society of Clinical Oncology endorses American Cancer Society Prostate Cancer Survivorship Care Guidelines
Prostate Cancer News Today
In the United States, according to recent estimations, nearly 3 million men have prostate cancer, and approximately 233,000 patients are expected to be diagnosed in 2014. Prostate cancer accounts for 20 percent of all cancer survivors in the U.S., and although there are guidelines addressing prostate cancer screening and treatment, they still need to be structured to optimize the survivorship experience of patients who have been treated for this disease.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Screening for psychosocial distress: A review
Oncology Nurse Advisor
A cancer diagnosis is often accompanied by many unanswered questions and concerns, leading to one of the most underestimated effects of cancer: psychosocial distress. In addition to personal and financial concerns, side effects of the disease and treatments can exacerbate the symptoms of distress. Distress is defined as "a multifactorial unpleasant emotional experience of a psychological, social, and/or spiritual nature that may interfere with the ability to cope effectively with cancer, its physical symptoms, and its treatment."
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Heart health after cancer: A growing concern
Nearly 15 million people are living after a cancer diagnosis in the United States. This number represent over 4 percent of the population, an astonishing figure. And a growing one, as reported last year by the American Cancer Society and outlined by the National Cancer Institute's Office of Cancer Survivorship. As cancer patients survive longer they face additional health problems. Radiation to the chest, chemotherapy, antibody therapy and hormone changes can affect blood vessels and heart function in the short term and long, during treatment or years later. But millions affected — and their physicians — remain insufficiently mindful about the risk of heart disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

New screening tests for hard-to-spot breast cancers
The Wall Street Journal
Millions of women in 21 states will get an ominous note with their mammogram results this year. Even if everything seems fine, they'll be informed that they have dense breast tissue, which can raise their risk for cancer and hide abnormalities, making their mammograms less accurate. The question is: now what?
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Register now for the NCDB Workshop and Survey Savvy
The NCDB Workshop and Survey Savvy will be held in Chicago on June 17- 19. The NCDB workshop Maximizing NCDB Data to Improve Your Cancer Program will review the current uses and future updates for the National Cancer Data Base (NCDB) quality tools. Major NCDB quality tools will be reviewed with a focus on how the data can be used to inform decisions for cancer program administration and by cancer physicians. Learn about the uses for the cancer registry and how patient navigators can use the data .

Survey Savvy provides in-depth review of the information your cancer committee needs to coordinate a high-quality, patient-centered, multidisciplinary cancer program. Developed by CoC staff and CoC committee leadership, this program addresses your cancer programs' most common questions, issues, and concerns regarding CoC standards and compliance.

Whether your cancer program is preparing for a re-accreditation survey or looking for clarification on the standards, this program provides increased understanding of standard requirements and implementation. Through lectures, panel presentations, and the opportunity to meet and speak with experts, cancer program members will learn how to use the CoC standards as a framework to develop a comprehensive cancer care program that delivers high-quality and patient-centered care. Plan now to attend these meetings.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Miss an issue of The Brief? Click here to visit The Brief archive page.

  Casefinding, Abstracting and Follow-up
We provide accurate oncology data collection with a team of experienced and credentialed consultants. For the highest oncology data quality standards, work with the team at Care Communications, Inc.

Learn more about Oncology Data Services.

Download our white paper: “Making Sense of the Rapid Quality Reporting System.”

Gene identified that lays foundation for pancreatic cancer
Medical News Today
A team of researchers have identified a gene that influences the shape of normal pancreatic cells and, as a result, could set the foundation for pancreatic cancer to develop. The study, published in Nature Communications, suggests that targeting the gene in question — protein kinase D1 — could lead to new ways of halting the development of one of the most difficult tumors to treat.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Register now for Pursuing Excellence through NAPBC Accreditation
Plan now to join us on April 24 at the Westin Westminster Denver-Boulder Hotel for the National Accreditation Program for Breast Centers (NAPBC) Pursuing Excellence through NAPBC Accreditation workshop. Attending this program — taught by experienced NAPBC committee members, board members, surveyors and staff — will give you the knowledge to develop and operate a high-quality breast center and achieve and maintain NAPBC accreditation. Registration for this program is now open.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Novartis blood cancer drug wins US OK after setback
The U.S. Food and Drug Administration recently approved Novartis AG's drug to treat patients who have relapsed after earlier therapies for multiple myeloma, an aggressive blood cancer, even though an advisory panel in November recommended against approval. The drug, Farydak, in clinical trials almost doubled to 10.6 months the amount of time it took for the disease to progress, compared with standard treatment. But it was associated with a wide array of serious side effects, including severe diarrhea and heart problems, which are prominently listed in a boxed warning.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
Looking for similar articles? Search here, keyword BLOOD CANCER.

Five cancer detection tests for early prevention
There are powerful reasons that to many, cancer is the dreaded Big C. Everyone knows someone fighting a battle with cancer or who has died from it. While many diagnosed individuals live to tell their tale, there is that initial confrontation with mortality that can be hard to overcome. Fortunately, with the improvements in modern medicine, there are good cancer detection tests that should be part of routine screening.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Missed last week's issue? See which articles your colleagues read most.

    New Affordable Care Act initiative to encourage better oncology care (Centers for Medicare & Medicaid Services)
Benefit of breast cancer prevention drug varies among at-risk women (Oncology Nurse Advisor)
Bringing incurable optimism to the fight against cancer (Bloomberg)
Education, not mandatory screening, best for women with dense
breast tissue
(Beth Israel Deaconess Medical Center via Medical Xpress)
Medicare moves toward value-based oncology payments (Modern Healthcare)

Don't be left behind. Click here to see what else you missed.

The Brief

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Ashley Whipple, Senior Content Editor, 469.420.2642
Contribute news

Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The CoC and NAPBC do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons, the CoC and the NAPBC.

Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of The Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

Feb. 18, 2015
Feb. 11, 2015
Feb. 4, 2015
Jan. 21, 2015

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063